Oral composition

By blending hyaluronic acid or its salts with zinc compounds, and optionally amino acids and/or sugars, the oral composition enhances adhesion to the oral cavity, ensuring a prolonged halitosis suppression effect.

JP2024158108APending Publication Date: 2024-11-08NIPPON ZETTOC CO LTD

Patent Information

Application Number
JP2023072996
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-04-27
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Oral compositions containing zinc compounds face challenges in maintaining halitosis suppression due to the ingredients being washed away by saliva and gargling, leading to inadequate adhesion to the oral cavity.

Method used

Incorporating hyaluronic acid or its salts with zinc compounds, optionally with amino acids and/or sugars, to enhance the adhesion and sustainability of the halitosis suppressing effect.

Benefits of technology

The composition achieves improved adhesion to teeth and oral mucosa, resulting in a sustained halitosis suppressing effect that lasts even after rinsing or saliva secretion.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024158108000001
    Figure 2024158108000001
  • Figure 2024158108000002
    Figure 2024158108000002
  • Figure 2024158108000003
    Figure 2024158108000003
Patent Text Reader

Abstract

To provide an oral composition that exhibits sustained inhibitory effect against oral malodor or the like.SOLUTION: An oral composition contains (A) a compound containing zinc metal or zinc and (B) hyaluronic acid or a salt thereof and also contains, optionally, (C) amino acids and / or saccharides.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to an oral composition. More specifically, the present invention relates to an oral composition containing zinc or a compound containing zinc and hyaluronic acid or a salt thereof, and uses thereof. [Background technology]

[0002] Conventionally, zinc compounds are known to be effective in preventing bad breath, and zinc compounds are widely used in oral compositions.Patent Document 1 shows that by combining zinc compounds with hyaluronic acid or its non-toxic salt, it has excellent anti-caries, tartar prevention, bad breath prevention, and anti-inflammatory effects, and improves usability.In addition, Patent Document 2 shows that an oral composition containing water-soluble zinc salt or zinc hydroxide, sodium bicarbonate, condensed phosphoric acid chelating agent, and charcoal powder has excellent bad breath prevention effects, and has good usability and formulation stability. On the other hand, oral compositions have the problem that the components do not remain in the oral cavity after application but flow out of the oral cavity due to the self-cleaning action of gargling and saliva, so the bad breath suppression effect of the zinc compound is difficult to sustain. Therefore, various studies have been conducted to improve the durability of the bad breath suppression effect. For example, Patent Document 3 shows that by blending a water-soluble copper compound, which is known to have a bad breath suppression effect like zinc compounds, with propylene glycol alginate in a specific mass ratio, the bad breath suppression effect is excellent and the feeling of use is improved. Furthermore, Patent Document 4 shows that a W / O emulsion type oral composition containing monoglyceride as the main base, polymer, bad breath removing active ingredient, and solvent binds with moisture such as saliva and changes to a cubic phase, thereby increasing viscosity and adhesion and showing a sustained bad breath removal effect. However, the above-mentioned oral compositions have not achieved a dramatic improvement in the adhesion of the deodorant ingredient to the teeth and oral mucosa. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] JP 2002-29950 A [Patent Document 2] JP 2022-100677 A [Patent Document 3] JP 2016-141661 A [Patent Document 4] Special Publication No. 2009-500399 Summary of the Invention [Problem to be solved by the invention]

[0004] An object of the present invention is to improve the above-mentioned problems. Another object of the present invention is to provide an oral composition that exhibits a sustained effect of suppressing bad breath. [Means for solving the problem]

[0005] After extensive research, the inventors have discovered that by combining a zinc compound with hyaluronic acid or a salt thereof, and optionally with amino acids and / or sugars, it is possible to improve the adhesion of the zinc compound to the oral cavity and / or to sustain the bad breath suppression effect of the zinc compound. Yet another aspect of the present invention may be as follows.

[0006] [1] An oral composition comprising (A) metallic zinc or a compound containing zinc, and (B) hyaluronic acid or a salt thereof. [2] (C) The oral composition described in [1] above, further containing amino acids and / or sugars. [3] The oral composition according to claim 1 or 2, wherein component (A) is one or more selected from zinc chloride, zinc glycine, and zinc oxide. [4] The oral composition according to [1] or [2] above, wherein the molecular weight of component (B) is in the range of 4.11 to 50,000,000. [5] The oral composition according to claim 2, wherein the component (C) is one or more selected from basic amino acids and / or neutral amino acids. [6] The oral composition according to claim 2, wherein the component (C) is one or more selected from arginine and glycine. [7] The oral composition according to claim 2, wherein the component (C) is one or more selected from saccharides having a cyclic structure in the molecule. [8] The oral composition according to claim 2, wherein the component (C) is one or more selected from sucralose, maltitol, sodium saccharin, and stevia. [9] The oral composition according to the above [1] or [2], wherein the content of the component (A) is 0.0001 to 5 mass% based on the total mass of the oral composition.

[10] The oral composition according to [1] or [2] above, wherein the content of the component (B) is 0.0001 to 1 mass % relative to the mass of the entire oral composition.

[11] The oral composition according to [2] above, wherein the content of component (C) is 0.001 to 10% by mass relative to the total mass of the oral composition.

[12] The oral composition according to [1] or [2] above, wherein the content of the (B) component is 0.00002 parts by mass to 10,000 parts by mass when the content of the (A) component is 1 part by mass.

[13] The oral composition according to [1] or [2] above, which has a pH in the range of 8 to 10.

[14] A long-lasting oral odor suppressant comprising the oral composition according to [1] or [2] above. Effect of the Invention

[0007] The present invention relates to an oral composition capable of improving adhesion of a deodorant ingredient to teeth, oral mucosa, etc. The present invention also relates to an oral composition exhibiting a sustained effect of suppressing bad breath. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0008] Here, the mode for carrying out the invention will be described in detail, but the preferred and more preferred embodiments exemplified below can be used in appropriate combination with each other regardless of expressions such as "preferred" and "more preferred". Furthermore, the descriptions of numerical ranges are merely examples, and ranges obtained by appropriately combining the upper and lower limits of each range and the numerical values ​​of the examples can also be preferably used. Furthermore, terms such as "contain" or "include" may be read as "essentially consisting of" or "consisting only of".

[0009] [Oral composition] The oral composition according to one embodiment of the present invention is a composition that contains (A) metallic zinc or a compound containing zinc, (B) hyaluronic acid or a salt thereof, and may further contain (C) amino acids and / or sugars. Each of these will be described in detail below.

[0010] (A) Metallic zinc or a compound containing zinc The metallic zinc or zinc-containing compound of component (A) is suitably added as a main active ingredient having an effect of suppressing bad breath. Metallic zinc means zinc element itself. As the zinc-containing compound of component (A), any compound containing zinc can be used, and examples thereof include zinc halide, zinc oxide, zinc hydroxide, organic zinc compounds, and inorganic zinc compounds. Here, examples of zinc halide include zinc fluoride, zinc chloride, zinc bromide, and zinc iodide, and zinc chloride is preferred. Examples of the organic zinc compound include organic acid zinc compounds which are compounds of zinc and an organic acid having 1 to 10 carbon atoms, such as zinc acetate or zinc oxalate, and preferably having 2 to 6 or 2 to 4 carbon atoms; hydrocarbon zinc compounds having one or more hydrocarbon groups having 1 to 10 carbon atoms, preferably having 2 to 6 or 2 to 4 carbon atoms; and amino acid zinc compounds which are compounds of zinc and an amino acid selected from valine, leucine, isoleucine, alanine, arginine, glutamine, lysine, aspartic acid, glutamic acid, proline, cysteine, threonine, methionine, histidine, phenylalanine, tyrosine, tryptophan, asparagine, glycine, and serine, and preferably zinc glycine. Examples of inorganic zinc compounds include compounds of zinc and Group 15 elements such as zinc nitride, zinc phosphide, zinc arsenide, and zinc antimonide; compounds of zinc and Group 16 elements such as zinc sulfide, zinc selenide, and zinc telluride; and inorganic acid zinc compounds, which are compounds of inorganic acids and zinc, such as zinc nitrate, zinc sulfate, zinc phosphate, zinc molybdate, zinc arsenite, zinc arsenate, zinc chromate, and zinc stannate. The above-mentioned (A) component may be used alone or in combination of two or more types. Particularly preferred as (A) component are zinc chloride, zinc glycine, and zinc oxide.

[0011] The content of the component (A) is, for example, 0.0001 to 5% by mass, preferably 0.001 to 1% by mass, and more preferably 0.02 to 0.1% by mass, based on the total mass of the oral composition. By setting the content of the component (A) within this range, a sufficient effect of suppressing bad breath can be obtained.

[0012] (B) Hyaluronic acid or its salt The component (B), hyaluronic acid or a salt thereof, is suitably added, for example, to improve the durability of the effect of suppressing bad breath. Hyaluronic acid is a polysaccharide represented by the following structural formula (I). The weight-average molecular weight of the hyaluronic acid or its salt is 411 or more, which is the minimum molecular weight of hyaluronic acid of n=1 in the above structural formula (I), and is, for example, 2000 to 50 million, preferably 10,000 to 10 million, more preferably 100,000 to 5 million, even more preferably 500,000 to 3.5 million, and particularly preferably 800,000 to 2 million or 1 million to 2.5 million. In another preferred embodiment, the molecular weight of the hyaluronic acid or its salt is 10,000 to 2.2 million or 850,000 to 2.2 million. In the structural formula (I), n is a numerical value that satisfies the molecular weight of the above-mentioned hyaluronic acid or its salt, and is, for example, 10,000 to 130,000, preferably 40,000 to 25,000, more preferably 240 to 12,500, even more preferably 1200 to 8600, and particularly preferably 1800 to 5000 or 2400 to 6100. In another preferred embodiment, n in the structural formula (I) is 24 to 5500 or 2000 to 5500. Examples of the salt of hyaluronic acid include compounds of Group 1 elements or Group 2 elements and hyaluronic acid, such as sodium hyaluronate, potassium hyaluronate, magnesium hyaluronate, and calcium hyaluronate. The above-mentioned (B) component may be used alone or in combination of multiple types.

[0013] The content of the (B) component is, for example, 0.0001 to 1 mass%, preferably 0.0005 to 0.01 mass%, more preferably 0.0008 to 0.003 mass%, based on the total mass of the oral composition. In another embodiment, the content of the (B) component is preferably 0.0006 to 0.0039%, more preferably 0.0008 to 0.001%, based on the total mass of the oral composition. By setting the content of the (B) component within this range, the duration of the bad breath suppressing effect can be sufficiently improved.

[0014] (C) Amino acids and / or sugars The amino acids and / or sugars of the (C) component are added as auxiliary agents to improve the durability of the bad breath suppression effect of the (B) component. Here, the amino acids can be selected from valine, leucine, isoleucine, alanine, arginine, glutamine, lysine, aspartic acid, glutamic acid, proline, cysteine, threonine, methionine, histidine, phenylalanine, tyrosine, tryptophan, asparagine, glycine, and serine. The amino acids are preferably basic amino acids and neutral amino acids, and more preferably arginine and glycine. When amino acids are used as the (C) component, it is preferable to use amino acid zinc as the metallic zinc or zinc-containing compound of the (A) component, and it is more preferable to use the same amino acid in the (A) component and the (C) component. As the saccharide, any saccharide can be used, including linear saccharides and saccharides having a cyclic structure, but it is preferable to use one or more selected from saccharides having a cyclic structure in the molecule.As linear saccharides, xylitol, glucose, sorbitol, erythritol, and mannitol can be mentioned.As saccharides having a cyclic structure in the molecule, for example, sucralose, maltitol, sodium saccharin, stevia, aspartame, and potassium acesulfame can be mentioned, and preferably sucralose, maltitol, sodium saccharin, and stevia. The component (C) may be used alone or in combination of two or more types.

[0015] The content of the (C) component is, for example, 0.001 to 10% by mass, preferably 0.005 to 1% by mass, more preferably 0.01 to 0.5% by mass, based on the total mass of the oral composition. In yet another embodiment, when the (C) component is an amino acid, the amino acid is, for example, 0.005 to 1% by mass, preferably 0.01 to 0.5% by mass, based on the total mass of the oral composition, and when the (C) component is a sugar, the sugar is, for example, 0.01 to 5% by mass, preferably 0.08 to 1% by mass, based on the total mass of the oral composition. By setting the content of the (C) component within this range, the duration of the bad breath suppressing effect can be sufficiently improved.

[0016] The above (A) to (C) components are preferably contained in the oral cavity composition in a specific ratio. Specifically, when the content of the (A) component is taken as 1 part by mass, the content of the (B) component is, for example, 0.00002 parts by mass to 10000 parts by mass, preferably 0.0005 parts by mass to 10 parts by mass, and more preferably 0.008 parts by mass to 0.16 parts by mass. In addition, when the content of the (A) component is taken as 1 part by mass, the content of the (C) component as amino acids is, for example, 0.0002 parts by mass to 100000 parts by mass, preferably 0.001 parts by mass to 1000 parts by mass, and more preferably 0.1 parts by mass to 25 parts by mass. Furthermore, when the content of the (A) component is 1 part by mass, the content of the (C) component as a saccharide is, for example, 0.0002 parts by mass or more and 100,000 parts by mass or less, preferably 0.01 parts by mass to 5,000 parts by mass, and more preferably 1 part by mass to 50 parts by mass. Without being bound by theory, it is believed that by not using an excessive amount of the (B) component relative to the (A) component and allowing it to exist within the above-mentioned moderate range, the oral composition can be sustained in the oral cavity while fully exerting the bad breath suppressing effect of the (A) component.

[0017] In addition to the above components (A) to (C), the oral cavity composition may contain optional components that are generally used in oral cavity compositions, as necessary. Examples of optional components include surfactants, abrasives, thickeners, humectants, solvents, sweeteners, flavorings, cooling agents, pH adjusters, preservatives, coloring agents, suspending agents, functional components, and flavoring components. These optional components may be appropriately selected within a range that does not impair the effects of the present invention, and may be blended in an appropriate amount. These optional components may be compounds that have multiple characteristics (for example, flavorings and cooling agents).

[0018] Examples of surfactants include sodium lauryl sulfate, sodium α-olefin sulfonate, sodium dodecylbenzenesulfonate, sodium lauryl sulfoacetate, sodium N-lauroyl sarcosinate, N-acyl glutamate, sucrose fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene block copolymer, alkyl glycosides, sorbitan fatty acid ester, glycerin fatty acid ester, polyoxyethylene sorbitan fatty acid ester, alkyl dimethylamine oxide, lauryl ethanolamide, sodium cocoyl sarcosinate, and sodium N-lauroyl methyl taurate solution. The amount of surfactant is generally 0.01% by mass to 10% by mass based on the total mass of the oral composition.

[0019] Examples of the abrasive include calcium carbonate, calcium phosphate, dibasic calcium phosphate, calcium pyrophosphate, insoluble calcium metaphosphate, hydrous silicic acid, anhydrous silicic acid, titanium dioxide, amorphous silica, crystalline silica, aluminosilicate, aluminum oxide, aluminum hydroxide, resin, etc. The amount of the abrasive to be blended is generally 0.01% by mass to 50% by mass based on the total mass of the oral cavity composition. Examples of thickeners include cellulose derivatives such as carrageenan, carboxymethylcellulose, sodium carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and hydroxypropylmethylcellulose, alkali metal alginates such as sodium alginate, propylene glycol alginate, gums such as xanthan gum, tragacanth gum, and gum arabic, synthetic thickeners such as polyvinyl alcohol, sodium polyacrylate, and polyvinylpyrrolidone, and inorganic thickeners such as silica gel, aluminum silica gel, and Veegum. The amount of the thickener is generally 0.01% by mass to 30% by mass based on the total mass of the oral composition. Examples of the humectant include polyhydric alcohols such as glycerin, sorbitol, polyethylene glycol, propylene glycol, ethylene glycol, 1,3-butylene glycol, polypropylene glycol, xylitol, maltitol, lactitol, etc. The amount of the humectant is generally 0.01% by mass to 99% by mass based on the total mass of the oral cavity composition.

[0020] Examples of the solvent include organic solvents such as ethanol, propyl alcohol, isopropyl alcohol, etc., water, etc. The blending amount of the solvent is generally 0.01% by mass to 99% by mass based on the total mass of the oral cavity composition. Examples of sweeteners include palatinit, aspartame, sodium saccharin, potassium acesulfame, stevioside, neohesperidyl dihydrochalcone, glycyrrhizin, perillarmine, thaumatin, aspartyl phenylalanyl methyl ester, ρ-methoxycinnamic aldehyde, sucralose, xylitol, stevia, etc. The amount of sweetener is generally 0.001% by mass to 10% by mass based on the total mass of the oral composition. Examples of the flavoring include blended flavorings such as strawberry flavor and apple flavor, terpenoid essential oils, phenylpropanoid essential oils, etc. The blending amount of the flavoring is generally 0.001% by mass to 5% by mass based on the total mass of the oral composition. Examples of cooling agents include N-ethyl-p-menthane-3-carboxamide, ethyl-3-(p-menthane-carboxamide) acetate, N-(4-cyanomethylphenyl)-p-menthane carboxamide, etc. The amount of the cooling agent is generally 0.001% by mass to 5% by mass based on the total mass of the oral cavity composition. Examples of the pH adjuster include phosphoric acid, pantothenic acid, malic acid, pyrophosphoric acid, lactic acid, tartaric acid, glycerophosphoric acid, acetic acid, nitric acid, silicic acid, citric acid, metaphosphoric acid, polyphosphoric acid and chemically possible salts thereof, as well as sodium hydroxide, potassium hydroxide, disodium hydrogen phosphate, sodium dihydrogen phosphate, dipotassium hydrogen phosphate, potassium dihydrogen phosphate, etc. The amount of the pH adjuster to be blended is generally 0.001% by mass to 20% by mass based on the total mass of the oral cavity composition.

[0021] Examples of preservatives include paraoxybenzoic acid esters, benzoic acid and its salts, salicylic acid and its salts, sorbic acid and its salts, phenoxyethanol, alkyldiaminoethylglycine hydrochloride, etc. The amount of the preservative is generally 0.001% by mass to 10% by mass based on the total mass of the oral cavity composition. Examples of colorants include dyes such as Blue No. 1, Green No. 3, Yellow No. 4, and Red No. 105, and pigments such as titanium dioxide, zinc oxide, and gunjo. The amount of the colorant is generally 0.01% by mass to 10% by mass based on the total mass of the oral composition. Examples of the suspending agent include oils and fats such as olive oil, camellia oil, castor oil, and emulsions containing these oils and fats. The amount of the suspending agent is generally 0.001% by mass to 5% by mass based on the total mass of the oral cavity composition. Examples of functional ingredients include glycyrrhizic acid and its salts, glycyrrhetinic acid, pyridoxine hydrochloride, ε-aminocaproic acid, allantoin, sodium chloride, ascorbic acid and its salts, ascorbic acid derivatives, tocopherol acetate, zeolite, sodium fluoride, sodium monofluorophosphate, polyethylene glycol, potassium nitrate, azulene sulfonic acid and its salts, aluminum lactate, and tranexamic acid. The amount of the functional ingredient is generally 0.001% by mass to 10% by mass based on the total mass of the oral composition. Examples of the flavoring ingredient include tea extract, dry distillation liquid of tea, sodium glutamate, etc. The blending amount of the flavoring ingredient is generally 0.001% by mass to 5% by mass based on the total mass of the oral cavity composition.

[0022] The oral composition of the present invention can be in various forms such as a paste, gel, liquid, etc. at room temperature (e.g., 25° C.±5° C.) Examples of the oral composition include toothpaste, gel toothpaste, liquid toothpaste, oral moisturizer, mouthwash, etc.

[0023] [Method of manufacturing oral composition] The oral composition can be produced by a general method for preparing a composition containing multiple components, such as mixing component (A) with component (B). The order of mixing the components is not particularly limited, and the components may be mixed one by one, or all of the components may be mixed at the same time. In addition to the mixing step, the oral composition can be prepared according to a process typically used in the manufacture of oral compositions, with the additional optional step of blending other bactericidal / antibacterial components and optional ingredients.

[0024] [Characteristics of oral compositions] The oral composition may be acidic, neutral, or alkaline, but is preferably neutral or alkaline, and more preferably weakly alkaline. The pH of the oral composition is, for example, 4.0 to 12.0, preferably 7.0 to 11.0, and more preferably 8.0 to 10.0. The oral composition can remain in the oral cavity without being washed away even if the oral cavity is gargled multiple times or saliva is secreted after use. For example, the oral composition can remain sufficiently in the oral cavity even after gargling with water 1 to 7 times, preferably 2 to 6 times, and more preferably 3 to 5 times, and the oral composition can continuously exert its halitosis suppressing effect. It is known that saliva is secreted at an average rate of 0.3 mL / min in normal people, and the oral composition can remain sufficiently in the oral cavity even if 10 mL or more of saliva is secreted, and the oral composition can continuously exert its halitosis suppressing effect. Whether or not the oral composition adheres to and remains in the oral cavity can be measured by determining whether or not a sufficient amount of the oral composition remains in the oral cavity even after the oral model has been washed 2 to 10 times, preferably 3 to 7 times, and more preferably 5±1 times with 2 mL of purified water or artificial saliva. When the amount of zinc adhered to the oral model is measured using sodium dihydrogen ethylenediaminetetraacetate solution (EDTA) as a reagent, it can be said that if, for example, 10 μg or more, preferably 30 μg or more, and more preferably 60 μg or more of zinc is adhered, the oral composition can be said to be able to exert a sustained bad breath suppression effect.

[0025] [Uses of oral compositions] The oral composition of the present invention is used to suppress bad breath in the oral cavity. Specifically, by keeping the oral composition (for example, 1 mL) in the oral cavity for, for example, 30 seconds to 6 minutes, preferably 1 to 5 minutes, more preferably 3 minutes ± 1 minute, the oral composition remains effective in the oral cavity and the bad breath suppressing effect is sufficiently maintained. The oral composition of the present invention is expected to have a particularly long-lasting bad breath suppressing effect, and without being bound by theory, the (A) component acts as an active ingredient for suppressing bad breath, while the (B) component and the optional (C) component act as ingredients for sustaining the (A) component in the oral cavity. In addition to simply keeping the oral composition in the oral cavity, it is appropriate to spread the oral composition to every corner of the oral cavity by methods such as rinsing, gargling, and brushing.

[0026] [Long-lasting breath odor suppressant] The oral composition of the present invention remains in the oral cavity for a long time and exerts a sustained effect of suppressing bad breath, so it can be used as a sustained bad breath suppressant. Specifically, the sustained bad breath suppressant may contain, in addition to the oral composition, other active ingredients such as other bad breath suppressants and oral cleansers, drugs such as anti-inflammatory agents and antibacterial agents, and additional solvents such as purified water. In particular, the oral composition of the present invention may be agent A, and an additional solvent such as purified water may be agent B, and the sustained bad breath suppressant may be provided as a kit of agent A and agent B, or only agent A may be used as a sustained bad breath suppressant by diluting it to an appropriate concentration (for example, 1.5 to 10 times, preferably 2 to 5 times) when used. EXAMPLES

[0027] Specific examples of the oral composition of the present invention will be described below, but it should be clearly noted that the examples are not intended to limit the scope of the present invention. Furthermore, % means mass % excluding the residual ratio.

[0028] [Components used in the Examples and Comparative Examples] The components used in the examples and comparative examples are as follows. Zinc chloride: manufactured by Junsei Chemical Co., Ltd. Glycine zinc: Nikko Chemicals Co., Ltd. Zinc oxide: manufactured by Hakusui Tech Co., Ltd. Copper gluconate: manufactured by Tomita Pharmaceutical Co., Ltd. Sodium hyaluronate 1 (weight average molecular weight 1.2 million to 2.2 million): Manufactured by Kewpie Corporation, product number: HA-LQH Sodium hyaluronate 2 (weight average molecular weight 850,000 to 1,600,000): Kewpie Corporation Product number: HA-LQ Sodium hyaluronate 3 (weight average molecular weight less than 10,000): Kewpie Corporation Hyalo Oligo Arginine: Sande Chemical Co., Ltd. Glycine: Organic Synthetic Chemicals Co., Ltd. Sucralose: San-Ei Gen F.F.I. Co., Ltd. Maltitol: Manufactured by Yakushi Chemical Co., Ltd. Sodium saccharin: Manufactured by Kongo Pharmaceutical Co., Ltd. Stevia: Manufactured by Maruzen Pharmaceuticals Co., Ltd. Xylitol: Produced by Bussan Food Science Co., Ltd.

[0029] [Preparation of oral composition of Example 1] The components shown in Example 1 of Table 1 were mixed using a magnetic stirrer to obtain the oral composition of Example 1. [Preparation of oral compositions of Examples 2 to 23 and Comparative Examples 1 to 9] Oral compositions of Examples 2 to 23 and Comparative Examples 1 to 9 were obtained in the same manner as in Example 1, except that the components were used in the proportions shown in Tables 1 to 7.

[0030] [Evaluation of sustained effect of suppressing bad breath] Vitroskin (IMS) cut into 1 cm squares was placed on a 24-well plate, and 1 mL of each component of the examples and comparative examples was added and soaked for 3 minutes. Each component of the examples and comparative examples was removed, and Vitroskin was washed five times with 2 mL of artificial saliva (a pH 7 aqueous solution containing 0.9 mM potassium dihydrogen phosphate, 1.5 mM calcium chloride, 20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), and 130 mM potassium chloride). After washing, Vitroskin was placed in a vial with a rubber stopper, and 1 mL of distilled water was added to the vial, and the vial was sealed with the rubber stopper to prevent volatile components from evaporating. Next, 10 μL of 200 μg / mL hydrogen sulfide solution was added to the sealed vial through the rubber stopper with a microsyringe. After incubation at 37°C for 30 minutes, 100 µL of hydrogen sulfide in the gas phase was collected using a gas-tight syringe and measured by gas chromatography (product name: GC-2014, manufacturer: Shimadzu Corporation). On the other hand, as a control, the above Vitroskin and 1 mL of distilled water were added to a vial with a rubber stopper, and the vial was sealed with the rubber stopper. 10 μL of 200 μg / mL hydrogen sulfide solution was added to the sealed vial through the rubber stopper with a microsyringe. After incubation at 37°C for 30 minutes, 100 μL of hydrogen sulfide in the gas phase was collected with a gas-tight syringe and measured by the above gas chromatography. The concentration of hydrogen sulfide in the gas phase of the vial in the control was taken as 100%, and the concentration of hydrogen sulfide in the gas phase of the vial in the examples and comparative examples was calculated as the residual rate (%), and the sustained bad breath suppression effect was evaluated according to the following criteria. A (best): Less than 13% B (Excellent): 13% to less than 40% C (Very good): 40% to less than 45% D (Good): 45% to less than 60% E (Acceptable): 60% to less than 64% F (bad): 64% to less than 84% G (very bad): 84% or more

[0031] Table 1 TIFF2024158108000002.tif109151

[0032] Table 2 TIFF2024158108000003.tif125162

[0033] Table 3 TIFF2024158108000004.tif187162

[0034] Table 4 TIFF2024158108000005.tif119145

[0035] Table 5 TIFF2024158108000006.tif140144

[0036] Table 6 TIFF2024158108000007.tif145139

[0037] Table 7 TIFF2024158108000008.tif145143

[0038] From the results in Tables 1 to 7 above, it was found that the oral composition of the present invention exhibits a sustained effect of suppressing bad breath. More specifically, the following points were clarified. From Examples 1 to 4 and Comparative Examples 1 and 2, it was found that the combination of (A) metallic zinc or a compound containing zinc and (B) hyaluronic acid or a salt thereof exhibits an excellent and sustained effect of suppressing bad breath. The results of Examples 1, 5-10, and 16-21 and Comparative Examples 1-3, 5, 7, and 9 show that when (A) metallic zinc or a compound containing zinc and (B) hyaluronic acid or a salt thereof are further combined with (C) amino acids, the effect is dramatically increased compared to the combination of only (A) and (B). From Examples 1, 11-15, 22, and 23 and Comparative Examples 1, 2, 4, 6, and 8, it was found that when (A) metallic zinc or a compound containing zinc and (B) hyaluronic acid or a salt thereof are further combined with (C) a sugar, the effect was dramatically increased compared to the combination of components (A) and (B) alone.

[0039] [Adhesion evaluation of metallic zinc or compounds containing zinc] Vitroskin (IMS) cut into 1 cm squares was placed on a 24-well plate, 1 mL of each component of the Examples and Comparative Examples was added, and the solution was collected after immersion for 3 minutes. Vitroskin was washed five times with 2 mL of artificial saliva (a pH 7 aqueous solution containing 0.9 mM potassium dihydrogen phosphate, 1.5 mM calcium chloride, 20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), and 130 mM potassium chloride), and the artificial saliva was also collected. The collected components of the Examples and Comparative Examples were combined with the collected artificial saliva, and the pH was adjusted to 5 with hydrochloric acid. Then, 0.5 mL of 0.1 M acetate buffer and one drop of 0.1% xylenol orange were added to prepare a sample solution. In a separate container, 10 mL of the same artificial saliva as above was added to 1 mL of each component of the Examples and Comparative Examples, and the solution was adjusted to pH 5 with hydrochloric acid. Then, 0.5 mL of 0.1 M acetate buffer and one drop of 0.1% xylenol orange were added to prepare a stock solution. The sample solution and the stock solution were titrated with 0.1 mM sodium dihydrogen ethylenediaminetetraacetate (EDTA) solution. The end point was when the color of each solution changed from reddish purple to yellow. The amount of zinc (μg) in each solution was calculated using the following formula, and the amount of zinc (μg) attached to Vitroskin was calculated. Amount of zinc in each solution (μg) = 0.1 (mM) x amount of EDTA dropped (mL) x 65.39 (molar mass of zinc) Amount of zinc attached to Vitroskin (μg) = Amount of zinc in the original solution (μg) - Amount of zinc in the sample solution (μg) The obtained zinc deposition amount was evaluated according to the following criteria. ◎ (Very good): The amount of zinc attached to Vitroskin is 60μg or more. ○ (Good): The amount of zinc attached to Vitroskin is between 10 μg and 60 μg. × (Poor): The amount of zinc attached to Vitroskin is less than 10 μg.

[0040] Table 8 TIFF2024158108000009.tif104152

[0041] From the results in Table 8 above, the oral composition of the present invention demonstrated an effect of adhering zinc to vitroskin. More specifically, the following points were clarified. From Example 1 and Comparative Example 1, it was shown that the combination of (A) metallic zinc or a compound containing zinc and (B) hyaluronic acid or a salt thereof provided an excellent zinc adhesive effect. The results of Examples 1 and 5 show that when (A) metallic zinc or a compound containing zinc and (B) hyaluronic acid or a salt thereof are combined with (C) amino acids, the effect is dramatically increased compared to when only components (A) and (B) are used. The results of Examples 1 and 11 show that when (A) metallic zinc or a compound containing zinc and (B) hyaluronic acid or a salt thereof are further supplemented with (C) a sugar, the effect is dramatically increased compared to when only components (A) and (B) are used.

[0042] [Prescription example] The following is a formulation example of the oral cavity composition of the present invention, which is prepared by blending component (A), component (B), and optionally component (C) and mixing optional components. The blend amounts are expressed in mass % when the entire formulation is taken as 100 mass %. It has been confirmed that the gel dentifrice, toothpaste, non-aqueous dentifrice, and liquid dentifrice described below can improve the adhesion of metallic zinc or a compound containing zinc to the oral cavity and / or can prolong the bad breath suppression effect of metallic zinc or a compound containing zinc.

[0043] [Formulation Example 1] Toothpaste Zinc chloride 0.025 Zinc Glycine 0.025 Zinc oxide 0.025 Sodium hyaluronate 0.001 Arginine 0.01 Glycine 0.01 Sucralose 0.1 Maltitol 0.1 Sodium saccharin 0.1 Stevia 0.1 Citric acid 0.05 Tartaric acid 0.05 Benzalkonium chloride 0.01 Benzethonium chloride 0.01 Silica 7.0 Hydrated silica 3.0 Calcium hydrogen phosphate 1.0 Titanium dioxide 0.3 Sodium carboxymethylcellulose 0.1 Sodium fluoride 0.1 Sodium lauryl sulfate 1.0 Sodium Methyl Lauroyl Taurate 0.5 Isopropyl methylphenol 0.1 Pyridoxine hydrochloride 0.1 70% Sorbitol Solution 10 Concentrated glycerin 20 Polyoxyethylene hydrogenated castor oil 1.0 Fragrance 1.0 Purified water remainder Total 100%

[0044] [Formulation Example 2] Non-aqueous toothpaste Zinc chloride 0.025 Zinc Glycine 0.025 Zinc oxide 0.025 Sodium hyaluronate 0.001 Arginine 0.01 Glycine 0.01 Sucralose 0.1 Maltitol 0.1 Sodium saccharin 0.1 Stevia 0.1 Citric acid 0.05 Tartaric acid 0.05 Benzalkonium chloride 0.01 Benzethonium chloride 0.01 Silica 10.0 Hydrated silica 5.0 Calcium hydrogen phosphate 1.0 Titanium dioxide 1.0 Propylene glycol alginate 0.1 Hydroxyethyl cellulose 0.1 Sodium carboxymethylcellulose 0.1 Hydroxypropyl cellulose 0.1 Hydroxypropyl methylcellulose 0.1 Polyvinylpyrrolidone 1.0 Sodium hydroxide 0.3 Sodium fluoride 0.1 Sodium Lauryl Sulfate 1.5 Sodium Methyl Lauroyl Taurate 0.5 Isopropyl methylphenol 0.1 Pyridoxine hydrochloride 0.1 Concentrated glycerin 20.0 Glycerin fatty acid ester 0.5 Polyoxyethylene hydrogenated castor oil 1.0 Fragrance 1.0 Propylene glycol remainder Total 100%

[0045] [Formulation Example 3] Gel-type toothpaste Zinc chloride 0.025 Zinc Glycine 0.025 Zinc oxide 0.025 Sodium hyaluronate 0.001 Arginine 0.01 Glycine 0.01 Sucralose 0.1 Maltitol 0.1 Sodium saccharin 0.1 Stevia 0.1 Citric acid 0.05 Tartaric acid 0.05 Benzalkonium chloride 0.01 Benzethonium chloride 0.01 Sodium carboxymethylcellulose 0.1 Hydroxyethyl cellulose 0.1 70% Sorbitol solution 10.0 Sodium fluoride 0.1 Concentrated glycerin 30.0 Dipotassium glycyrrhizinate 0.1 Isopropyl methylphenol 0.1 Sodium Lauroyl Sarcosinate 0.1 Polyoxyethylene hydrogenated castor oil 0.5 Glycerin fatty acid ester 0.5 Fragrance 1.0 Purified water remainder Total 100%

[0046] [Formulation Example 4] Liquid toothpaste Zinc chloride 0.025 Zinc Glycine 0.025 Zinc oxide 0.025 Sodium hyaluronate 0.001 Arginine 0.01 Glycine 0.01 Sucralose 0.1 Maltitol 0.1 Sodium saccharin 0.1 Stevia 0.1 Benzalkonium chloride 0.01 Xanthan gum 0.5 Sodium hydroxide 0.42 Propylene glycol alginate 0.1 Dipotassium glycyrrhizinate 0.1 Sorbitol 7 Concentrated glycerin 30 Polyoxyethylene hydrogenated castor oil 0.5 Fragrance 1.0 Purified water remainder Total 100%

Claims

1. An oral composition comprising (A) metallic zinc or a compound containing zinc, and (B) hyaluronic acid or a salt thereof.

2. The oral composition according to claim 1 , further comprising (C) amino acids and / or sugars.

3. 3. The oral composition according to claim 1, wherein component (A) is one or more selected from zinc chloride, zinc glycine, and zinc oxide.

4. The oral composition according to claim 1 or 2, wherein the molecular weight of component (B) is in the range of 4.11 to 50,000,000.

5. 3. The oral composition according to claim 2, wherein the component (C) is one or more selected from the group consisting of basic amino acids and / or neutral amino acids.

6. 3. The oral composition according to claim 2, wherein the component (C) is at least one selected from arginine and glycine.

7. 3. The oral composition according to claim 2, wherein the component (C) is one or more selected from saccharides having a cyclic structure in the molecule.

8. 3. The oral composition according to claim 2, wherein the component (C) is one or more selected from the group consisting of sucralose, maltitol, sodium saccharin, and stevia.

9. 3. The oral composition according to claim 1, wherein the content of component (A) is 0.0001 to 5 mass% relative to the mass of the entire oral composition.

10. The oral composition according to claim 1 or 2, wherein the content of component (B) is 0.0001 to 1 mass % relative to the mass of the entire oral composition.

11. The oral composition according to claim 2, wherein the content of component (C) is 0.001 to 10% by mass relative to the total mass of the oral composition.

12. 3. The oral composition according to claim 1, wherein the content of the (B) component is 0.00002 parts by mass to 10,000 parts by mass when the content of the (A) component is 1 part by mass.

13. The oral composition according to claim 1 or 2, which has a pH in the range of 8 to 10.

14. A long-lasting breath odor suppressant comprising the oral composition according to claim 1 or 2.

Citation Information

Patent Citations

  • Toothpaste

    CN106389283A

  • Heat-clearing analgesic toothpaste

    CN107669610A

  • Composition with added natural antibacterial repairing components, preparation method and application of composition

    CN110893149A

  • Zinc compound-containing composition for oral cavity

    JP2002029950A

  • Phase change breath freshener

    JP2009500399A

Cited By

  • Non-aqueous dentifrice comprising hyaluronic acid

    EP4785925A1

  • Non-aqueous dentifrice comprising hyaluronic acid

    WO2026162531A1